documents: FDA-2015-N-1260-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2015-N-1260-0002 FDA FDA-2015-N-1260 Reference 5 Letter to K. Irwin, President and CEO, Omni Neutraceuticals, Inc., from D. Horowitz, Acting Director, Office of Compliance, CDER, re ‘‘Inholtra Joint Pain Caplets and Inholtra Joint Pain Plus’’ (October 16, 2001). Supporting & Related Material Background Material 2015-12-23T05:00:00Z 2015 12     2015-12-23T21:57:20Z   0 0 0900006481dcf789

Links from other tables